Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

15 mars 2016 16h30 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Announces Fourth Quarter and Year-End 2015 Financial Results

CORAL GABLES, Fla., March 15, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing...
10 mars 2016 11h55 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals to Present at the 28th Annual ROTH Conference

CORAL GABLES, Fla., March 10, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies...
09 mars 2016 08h03 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals to Hold Fourth Quarter Financial Results Conference Call and Webcast on Wednesday, March 16th, 2016

CORAL GABLES, Fla., March 09, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies...
29 févr. 2016 08h03 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Observes Rare Disease Day 2016

CORAL GABLES, Fla., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
26 févr. 2016 08h03 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Appoints Brian Elsbernd as Senior Vice President of Legal and Compliance

CORAL GABLES, Fla., Feb. 26, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies...
18 févr. 2016 11h38 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Announces Participation at SunTrust Robinson Humphrey’s 2016 Orphan Drug Day

CORAL GABLES, Fla., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
17 févr. 2016 06h50 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Receives "Refusal to File" Letter From the FDA on Its NDA for Firdapse

CORAL GABLES, Fla., Feb. 17, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
08 févr. 2016 08h03 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Announces Initiation of Investigator-Sponsored Study of Firdapse in Patients With MuSK-Antibody Positive Myasthenia Gravis

CORAL GABLES, Fla., Feb. 08, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
04 févr. 2016 08h03 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals to Present at the 18th Annual BIO CEO & Investor Conference

CORAL GABLES, Fla., Feb. 04, 2016 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...
17 déc. 2015 08h03 HE | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals Completes NDA Submission to FDA for Firdapse for the Treatment of Lambert-Eaton Myasthenic Syndrome and Congenital Myasthenic Syndromes

CORAL GABLES, Fla., Dec. 17, 2015 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...

Page précédente